| answer text |
<p>DFID invests in the Global Fund to Fight AIDS, TB and Malaria as the principal
mechanism to combat TB. The UK is currently the second largest investor in the Global
Fund, pledging £1.4 billion to the 6<sup>th</sup> Replenishment (2020 – 2022) and
£1.2 billion for the 5<sup>th</sup> Replenishment (2017-2019).</p><p>As our investment
in the Global Fund has increased our bilateral programmes have decreased. Bilateral
spending on TB control in 2018, which we publish by calendar year, was £1,862,966.</p><p>We
also fund research on TB, including to develop more effective diagnostics and treatment,
programmes to support countries to strengthen their health systems. Additionally,
we significantly invest into health multilaterals such as the World Health Organisation
and Unitaid, which provide technical leadership on tackling TB and strengthening health
systems, support the introduction of new drugs for drug-resistant TB and the development
of paediatric TB medicines for children in some of the world’s poorest countries.</p><p>Data
on UK aid expenditure is published each year and can be accessed from the link below:</p><p><a
href="https://www.gov.uk/government/statistics/statistics-on-international-development-final-uk-aid-spend-2018"
target="_blank">https://www.gov.uk/government/statistics/statistics-on-international-development-final-uk-aid-spend-2018</a></p>
|
|
